Tennessee Lawmakers Open Medical Marijuana Hearings as TBI Pushes Back

Hearings open with law enforcement on record

Tennessee legislators started formal medical marijuana hearings, and the first notable testimony came from law enforcement, not patients or operators.

The Chattanooga Times Free Press reported the hearings on Oct. 6, 2026. Its headline said a representative of the Tennessee Bureau of Investigation called marijuana a 'dangerous drug.' CannIntel had only the published headline and summary when this report was written, so the account below is limited to what that source supports.

Here the stakes are structural. Tennessee has no comprehensive medical cannabis market, so whatever framework emerges would decide who holds a license, how revenue is taxed and whether operators inherit the federal tax penalty under 280E.

What the TBI position signals

A state investigative agency opposing medical marijuana in the first hearing suggests any bill will be drafted around enforcement concerns.

That's not a surprise, since agencies that police controlled substances rarely volunteer to endorse a legal market, and the TBI's role makes its view relevant to licensing, background checks and diversion controls.

Still, one agency's characterization isn't a vote count. Hearings are where positions get recorded, not where bills are decided.

What the signal doesn't tell us

The headline doesn't identify the committee, the bill number, the TBI witness or any proposed licensing or tax terms.

Those gaps matter for compliance planning. Without statutory text, no one can say whether the legislature is weighing a narrow patient-access measure, a vertically integrated license model or a study committee.

CannIntel will update this report when the hearing record and any bill text are available.

The 280E problem, read literally

On a strict reading, IRC §280E turns on federal drug schedule status, not on whether a state has legalized the activity.

The statute bars deductions and credits for any trade or business that consists of trafficking in controlled substances 'within the meaning of schedule I and II' of the Controlled Substances Act. State authorization doesn't change that text. A Tennessee licensee selling marijuana would be tested against the federal schedule in force for the tax year, so a change in federal scheduling would change the analysis. A state program alone wouldn't.

For operators, that means cost of goods sold becomes the main lever, and the state's license structure will influence what qualifies as inventory cost. The math is brutal when a business can't deduct rent, payroll or marketing outside COGS.

Where Tennessee's tax code would intersect

Tennessee's business taxes, the franchise and excise taxes under Title 67, would reach licensed cannabis businesses regardless of the personal income tax picture.

Wages go untaxed in Tennessee, but the state levies an excise tax of 6.5% on net earnings and a franchise tax measured by net worth or property. The excise base generally starts from federal taxable income. On a strict reading, a 280E disallowance at the federal level would therefore flow into the state calculation unless the legislature writes a decoupling provision.

Decoupling is the question to watch. Several legalizing states have addressed it by statute, and the choice can be worth more to operators than the license fee itself.

Neighbors set the competitive context

Tennessee borders states that already authorize medical cannabis, including Kentucky, Arkansas, Missouri and Mississippi, which sharpens the cross-border revenue argument.

Lawmakers in states without programs often hear that patients cross state lines to buy elsewhere. Whether that argument carries weight in Tennessee will depend on testimony that hasn't yet been reported in detail. Supporters would need data. Opponents have already supplied a frame.

For full background on this story, see the CannIntel topic hub on Tennessee medical marijuana legislation.

What operators and investors should track

Until bill text appears, the actionable signals are the hearing schedule, any sponsor's draft and whether revenue officials are asked to testify.

A fiscal note from the state would show how lawmakers expect to tax the product and whether they've considered 280E. THC potency caps, DEA scheduling developments and any banking provisions would also shape the economics.

Watch for the committee's next hearing date, and for whether a bill with specific license and tax language gets filed before the session opens.